FDA: New side effect warning on GLP-1 drugs
GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News' "The Daily Report" to discuss.
Watch CBS News
GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News' "The Daily Report" to discuss.
Former top HHS aide Calley Means alleged in an interview with "Face the Nation" that Ballard Partners "controlled" White House policy. The firm and Wiles said the claims are false.
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.
The Food and Drug Administration plans to update nutrition standards for infant formula. Pediatrician Dr. Amanda Kravitz has more on the changes.
Health and Human Services Secretary Robert F. Kennedy Jr. took steps Wednesday that could open up access to certain unapproved peptide drugs that are being promoted for wellness.
Health Secretary Robert F. Kennedy Jr. took steps on Wednesday that could expand access to some unapproved drugs called peptides, which are being promoted for wellness. But there's not much evidence that they are safe and effective. Dr. Jon LaPook breaks it down.
While unverified, the reports come amid growing efforts to clamp down on illicit sales of the experimental weight-loss drug retatrutide.
Two recent deaths reported to the FDA could be linked to Retatrutide, an unapproved weight-loss drug made popular on social media. CBS News investigative reporter Daniel Gilbert has the latest.
Two deaths were reported to the U.S. Food and Drug Administration that may be tied to the use of bootleg weight-loss drugs, documents reviewed by CBS News show.
Recalled Gatorade sold in 37 states could cause temporary "adverse health consequences," a federal regulatory agency says.
Retatrutide is the latest experimental weight-loss drug with promising clinical trial results, but it's not yet approved by the FDA. Dr. Céline Gounder has the latest.
California food manufacturer said it is investigating after a consumer posted a video showing a rodent in a jar of the company's peperoncinis.
Recent outbreaks of foodborne illness and high-profile recalls have made food safety a concern of voters.
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts."
U.S. officials have confirmed cases of a parasitic illness tied to lettuce in three more states: Georgia, Tennessee and Texas.
Patients taking the first-of-a-kind pill, called daraxonrasib, lived for a median of 13.2 months compared with 6.7 months for chemotherapy recipients, studies showed.
It feels like there's been a new food recall every week this summer, but former FDA Commissioner Scott Gottlieb says the number of recalls has been on par with other years. CBS News medical correspondent Dr. Céline Gounder joins "The Takeout" with more.
The USS Washington arrived in the Middle East from Asia on Thursday and relieved the USS Lincoln after a nine-month deployment. The move comes as the Trump administration says it will unveil the "toughest sanctions" on Iran. CBS News' Margaret Brennan and Elliot Ackerman have more.
President Trump announced he's nominating Dr. Heidi Overton, a deputy assistant to the president for domestic policy, to be the next head of the FDA.
The FDA has long fallen short of legally required inspection targets, and foreign inspections fell further last year amid agency layoffs.
CBS News has learned that the Mexican lettuce farm connected to the outbreak of a nasty intestinal illness hasn't been inspected by American regulators in more than seven years. Food safety advocates blame budget and personnel cuts for a 29% drop in inspection rates of foreign farms over the past two years.
The restaurant chain said it pulled the peppers and replaced them with product from another grower amid a food-poisoning probe.
Drugmaker Eli Lilly says it is expanding access to its experimental weight loss drug, retatrutide, which has not been approved yet by the FDA. The company says obese patients taking the drug in clinical trials lost between 73 and 85 pounds over two years. Dr. Rachel Pessah Pollack discusses what we know about its safety, who is eligible for the medication and more.
Two people have died of cyclosporiasis in Michigan, officials said Monday, as the state battles the worst outbreak of the disease in the country. Carter Evans has the details.